论文部分内容阅读
近年来,肿瘤核素内照射治疗的研究取得了很大的进展。~(90)Y被视为绿色无公害核素备受关注。~(90)Y玻璃微球通过肝动脉给药,可以发挥栓塞肿瘤供血动脉和内照射治疗肿瘤的双重作用,具有操作简单、适应证广泛、不良反应少及肿瘤响应明显等优点,有效地提高了患者的生存率和中位生存期。随着微球材料技术的进一步发展,~(90)Y徽球肝动脉灌注可能成为治疗肝癌患者安全有效、具有广阔临床应用前景的新方法。
In recent years, the study of tumor nuclide irradiation has made great progress. ~ (90) Y is regarded as a green nuisance nuisance. ~ (90) Y glass microspheres through the hepatic artery can play the dual role of embolization of tumor feeding artery and internal irradiation in the treatment of tumors, with simple operation, extensive indications, fewer adverse reactions and tumor response and so on, effectively improve The patient’s survival rate and median survival. With the further development of microsphere material technology, ~ (90) Y emblem hepatic artery perfusion may become a new method to treat patients with hepatocellular carcinoma safely and effectively and have broad clinical application prospects.